Potassium Carbonate → HCID 70974927, compound

HRID 1477219Notes

Reaction equation

HRID 1477219 reaction equation
Br[C:2]1[C:7]([CH2:8][N:9]2[N:18]=[CH:17][C:16]3[C:11](=[CH:12][C:13]([C:19]4[CH:24]=[CH:23][C:22]([O:25][C:26]([F:29])([F:28])[F:27])=[CH:21][CH:20]=4)=[CH:14][CH:15]=3)[C:10]2=[O:30])=[CH:6][CH:5]=[CH:4][N:3]=1.[CH:31]1(B(O)O)[CH2:33][CH2:32]1.C(=O)([O-])[O-].[K+].[K+]>O1CCOCC1>[CH:31]1([C:2]2[C:7]([CH2:8][N:9]3[N:18]=[CH:17][C:16]4[C:11](=[CH:12][C:13]([C:19]5[CH:24]=[CH:23][C:22]([O:25][C:26]([F:29])([F:28])[F:27])=[CH:21][CH:20]=5)=[CH:14][CH:15]=4)[C:10]3=[O:30])=[CH:6][CH:5]=[CH:4][N:3]=2)[CH2:33][CH2:32]1

Participants

5

Conditions

Temperature
100 °C

Procedure

A mixture of 2-((2-bromopyridin-3-yl)methyl)-7-(4-(trifluoromethoxy)phenyl)phthalazin-1(2H)-one (25 mg, 0.053 mmol), cyclopropyl boronic acid (14 mg, 0.16 mmol), dppf(Pd)Cl2 (6 mg, 0.0079 mmol), potassium carbonate (29 mg, 0.021 mmol) in degassed dioxane (1 mL) was heated at 100° C. for 3 hours. The layers were separated, the organic layer was concentrated and the residue was purified by reverse phase HPLC to provide 2-((2-cyclopropylpyridin-3-yl)methyl)-7-(4-(trifluoromethoxy)phenyl)phthalazin-1(2H)-one as a white powder. C2-4H18F3N3O2. 438.1 (M+1).

Workup

  1. customThe layers were separated
  2. concentrationthe organic layer was concentrated
  3. customthe residue was purified by reverse phase HPLC

Sources & evidence

ORD record
ord-e985dccc356542409f722a7fa513e64c
Source dataset
uspto-grants-2016_08
Patent number
US09403782B2

Reaction notes

Loading…